Amarin Corp. PLC

Amarin Corp. PLC ADR
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
296.35 M
Public Float
-
Amarin Corp. PLC ADR
Stock Exchange NASDAQ Stock Market
EPS
$0.38
Market Cap
$7.66 B
Shares Outstanding
330.64 M
Public Float
288.38 M

Profile

Address
2 Pembroke House
Dublin Dublin 2
Ireland
Employees -
Website http://amarincorp.com
Updated 07/08/2019
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It's product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale.

Financials

View All
Created with Highcharts 5.0.14Amarin Corp. PLC ADRNet Income. Fiscal year is January-December. All values USD Thousands.165 744165 74456 13556 135148 779148 77985 75385 75368 59268 592116 248116 248201320142015201620172018050k100k150k200k
Created with Highcharts 5.0.14Amarin Corp. PLC ADRSales/Revenue. Fiscal year is January-December. All values USD Thousands.26 27426 27453 98253 98281 60281 602129 185129 185183 045183 045228 826228 826201320142015201620172018050k100k150k200k250k

John F. Thero
President, Chief Executive Officer & Director
Lars G. Ekman
Non-Executive Chairman